On average, drug companies spend 10 to 15 years developing, validating, and marketing a new product. Recent pandemics, like COVID, have shown the potential of digital tools to accelerate this process. The pharmaceutical industry is undergoing digital transformation across their whole value chain to reduce their “go to market” time.
However, digitalization can be complicated and difficult to achieve.
Do you recognize these trends in your industry?
Trend #1: facilitating company-wide data access to accelerate innovation
Pharmaceutical companies generate massive volumes of information (ingredient information, clinical trial data, production data and quality control reports). Sharing this data with new partners to collaborate and accelerate your R&D process is becoming the norm. Without easy access, these new data flows quickly pile up and make search and retrieval challenging and very time consuming.
How do you build a solid and flexible IT foundation to carry these data loads?
Trend #2: Accelerating therapeutics innovation with cognitive tools
New digital technologies, such as AI, are redesigning drug development processes and the entire supply chain. Enabling inventory prediction, supply chain monitoring, streamlining vaccine development, distribution, and accessibility.
But to use AI in workflows, the IT infrastructure must be evaluated. Is it ready to handle the growing need for speed, number of users and quantity of data?
Trend #3: Protecting proprietary information
Your critical company data is precious for competitors and malevolent individuals. With the growth of cyberattacks and medical identity theft, implementing robust security strategies in the your industry is an urgent matter.
Bridging cloud-based collaborative platforms with secure channels where researchers and clinicians can safely share sensitive information is becoming the standard in the pharmaceutical industry.
Do you guarantee safe transition of data between all of these sources and users?
Your challenges, our solutions
Eurofiber can help you strengthening to embrace these digital challenges.
Not only because of our 20 year experience in custom made connectivity solutions for the enterprise market. But also thanks to our experience and footprint with pharmaceutical companies like Catalent, Cellcarta, EG, Galapagos, Organon and Sterima.
They trust Eurofiber for their connectivity needs and as key enabler for their cloud transition.
Is connectivity crucial for your organization too?
Find out how our connectivity helps solve pharmaceutical sector challenges.